BIO International 2024
We know that there are significant hurdles for companies like yours striving to succeed in today’s high-stakes biopharma market. Syneos Health can help you maximize value, achieve your full asset potential and successfully navigate through these modern market realities in many ways, such as:
Our Consulting group has extensive experience with licensing support, asset searches, and market and opportunity assessments. We support companies in portfolio strategy, licensing and commercialization strategy, and have conducted asset search projects via structured methodology.
Our Syneos One® team provides seamless delivery of asset development solutions, bringing in the right resources and expertise spanning all clinical development, medical affairs, and commercialization services needed to bring products to market, address unmet patient needs and maximize value for stakeholders.
Syneos Health FSP 360 provides a customized outsourcing approach that prioritizes flexibility and fit-for-purpose solutions, easing the burden of resource management and functional delivery while enabling sponsor visibility and control of clinical development.
With our integrated data-driven technology-enabled solutioning, we enable better patient enrollment, retention, and ensure more representative research – helping sponsors advance treatments that impact patient lives and making clinical research easier for sites, patients, and sponsors.
StudyKIK, a Syneos Health company, began as a global network of patient-focused communities, giving us direct access to qualified patients covering virtually every major therapeutic area.
We have extensive experience and expertise in real world research, having delivered studies globally for 150+ customers and managing the most pregnancy registries and time & motion studies in the industry.
Syneos Health Value & Access helps you confidently navigate the shifting market landscape, create and communicate value, and optimize access through an integrated team custom-built to meet the needs of your product from clinical development to loss of exclusivity.
Meet with Us
Our team of experts will be on the floor at BIO 2024 to discuss how we can help you plan at any point along your product development journey.
Find us in the Business Forum or schedule a meeting to discuss your pressing challenges.
Related Content:
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Biotech & Commercialization
Investing for Launch Success: Tailoring Your Strategy for Europe
VIDEO | The Marriage of Biotech Innovators and Big Pharma: Bringing New Drugs to Market
VIDEO | De-Risking Investment to Deliver Innovation
Importance of the Right Go-to-Market Strategy in Cell Therapy Commercialization
Clinical Innovation & Operations
FSP Models Aren't Just for Large Pharma Anymore
Bring Your Clinical Trial to Australia for Global Reach and Local Experience
Three Lessons Learned in Adoptive Cell Therapy Trials: A Look at the Road Ahead for Immunology
Artificial Intelligence, Machine Learning and a New Epoch for Clinical Trials
WEBINAR | Optimizing Diversity in Oncology Trials: A Site-Specific Approach
Regulatory & Access
Using Real World Evidence for Externally Controlled Trials in Rare Disease Drug Development
BLOG: A Journey from Regulatory Compliance to Regulatory Excellence
Syneos Health Podcast| Patient Assistance Programs
Syneos Health Podcast | Real Talk About the Inflation Reduction Act
